Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lavergne

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 4, 2008
A base-labile group for 2'-OH protection of ribonucleosides: a major challenge for RNA synthesisThomas Lavergne, Jean-Rémi Bertrand, Jean-Jacques Vasseur, et al.
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Cardiac arrhythmias in the elderly]Louis Guize, Olivier Piot, Thomas Lavergne, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 30, 2012
Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approachJean-Yves Le Heuzey, Eloi Marijon, Thomas Lavergne, et al.
Current Protocols in Nucleic Acid Chemistry|December 15, 2010
Chemical synthesis of RNA with base-labile 2'-o-(pivaloyloxymethyl)-protected ribonucleoside phosphoramiditesThomas Lavergne, Michaël Janin, Christelle Dupouy, et al.
Pacing and Clinical Electrophysiology : PACE|April 12, 2003
Long-term experience with a preshaped left ventricular pacing leadJacky Ollitrault, Philippe Ritter, Philippe Mabo, et al.
Biomedical Informatics Insights|September 21, 2013
Combining an expert-based medical entity recognizer to a machine-learning system: methods and a case studyPierre Zweigenbaum, Thomas Lavergne, Natalia Grabar, et al.
Heartrhythm Case Reports|May 2, 2022
Long-term freedom from ventricular fibrillation despite persistent Purkinje ectopy after catheter ablationElodie Surget, Josselin Duchateau, Thomas Lavergne, et al.
Organic & Biomolecular Chemistry|March 5, 2013
The biolabile 2'-O-pivaloyloxymethyl modification in an RNA helix: an NMR solution structureCarine Baraguey, Eveline Lescrinier, Thomas Lavergne, et al.
Journal of the American Chemical Society|October 11, 2011
Site-specific labeling of DNA and RNA using an efficiently replicated and transcribed class of unnatural base pairsYoung Jun Seo, Denis A Malyshev, Thomas Lavergne, et al.
Organic Letters|April 28, 2010
Efficient solid-phase chemical synthesis of 5'-triphosphates of DNA, RNA, and their analoguesIvan Zlatev, Thomas Lavergne, Françoise Debart, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 4, 2008
A base-labile group for 2'-OH protection of ribonucleosides: a major challenge for RNA synthesisThomas Lavergne, Jean-Rémi Bertrand, Jean-Jacques Vasseur, et al.
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Cardiac arrhythmias in the elderly]Louis Guize, Olivier Piot, Thomas Lavergne, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 30, 2012
Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approachJean-Yves Le Heuzey, Eloi Marijon, Thomas Lavergne, et al.
Current Protocols in Nucleic Acid Chemistry|December 15, 2010
Chemical synthesis of RNA with base-labile 2'-o-(pivaloyloxymethyl)-protected ribonucleoside phosphoramiditesThomas Lavergne, Michaël Janin, Christelle Dupouy, et al.
Pacing and Clinical Electrophysiology : PACE|April 12, 2003
Long-term experience with a preshaped left ventricular pacing leadJacky Ollitrault, Philippe Ritter, Philippe Mabo, et al.
Biomedical Informatics Insights|September 21, 2013
Combining an expert-based medical entity recognizer to a machine-learning system: methods and a case studyPierre Zweigenbaum, Thomas Lavergne, Natalia Grabar, et al.
Heartrhythm Case Reports|May 2, 2022
Long-term freedom from ventricular fibrillation despite persistent Purkinje ectopy after catheter ablationElodie Surget, Josselin Duchateau, Thomas Lavergne, et al.
Organic & Biomolecular Chemistry|March 5, 2013
The biolabile 2'-O-pivaloyloxymethyl modification in an RNA helix: an NMR solution structureCarine Baraguey, Eveline Lescrinier, Thomas Lavergne, et al.
Journal of the American Chemical Society|October 11, 2011
Site-specific labeling of DNA and RNA using an efficiently replicated and transcribed class of unnatural base pairsYoung Jun Seo, Denis A Malyshev, Thomas Lavergne, et al.
Organic Letters|April 28, 2010
Efficient solid-phase chemical synthesis of 5'-triphosphates of DNA, RNA, and their analoguesIvan Zlatev, Thomas Lavergne, Françoise Debart, et al.
Pageof 8